Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 24013690)

Published in Bone Marrow Transplant on September 09, 2013

Authors

H Shiozaki1, K Yoshinaga1, T Kondo1, Y Imai1, M Shiseki1, N Mori1, M Teramura1, T Motoji1

Author Affiliations

1: Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Articles cited by this

Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A (2002) 2.58

Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol (2011) 1.91

Donor cell leukemia: a review. Biol Blood Marrow Transplant (2010) 1.86

Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79

Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation. Leukemia (2006) 1.77

In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood (2002) 1.71

Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood (2007) 1.61

Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol (1999) 1.47

Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica (2005) 1.45

Very late recurrences of leukemia: why does leukemia awake after many years of dormancy? Leuk Res (2011) 1.39

Leukaemic transformation of engrafted bone marrow cells. Br J Haematol (1985) 1.18

Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1972) 1.17

Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol (2006) 1.14

Unrelated umbilical cord blood transplantation and immune reconstitution. Semin Hematol (2010) 1.12

Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Bone Marrow Transplant (2002) 1.08

Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.06

Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol (2006) 1.05

First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood (2005) 1.04

Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol (2000) 1.00

Chromosomal transformation in donor cells following allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 0.98

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am J Hematol (2005) 0.97

Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet (2003) 0.97

Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med (1991) 0.95

Donor cell-derived acute monoblastic leukemia involving MLL gene translocation in an adult patient who received umbilical cord blood transplantation. Bone Marrow Transplant (2007) 0.94

Improving outcomes in umbilical cord blood transplantation: state of the art. Blood Rev (2012) 0.91

Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia. Pediatr Transplant (2011) 0.90

Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Leuk Res (2004) 0.89

The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res (1982) 0.88

Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia. Hum Pathol (2013) 0.87

Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Engl J Med (1981) 0.87

A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Bone Marrow Transplant (2000) 0.87

Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant (2002) 0.85

Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood Bank. Cytotherapy (2007) 0.84

Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood (1978) 0.84

Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: Report of a new case and review of the literature. Genet Mol Biol (2012) 0.84

Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol (2003) 0.83

Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol (2002) 0.83

Therapy-related, donor-derived AML responding to a second allogeneic BMT. Bone Marrow Transplant (2007) 0.83

Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Engl J Med (1984) 0.81

Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation. Exp Hematol (2011) 0.81

Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Am J Hematol (2006) 0.81

Leukaemia arising in donor cells following allogeneic bone marrow transplantation for beta thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol (1993) 0.81

Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia. Int J Biomed Sci (2012) 0.81

Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma. Int J Hematol (2009) 0.81

Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant (2001) 0.80

Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood (1985) 0.80

Donor cell-derived myelodysplastic syndrome after cord blood transplantation. Bone Marrow Transplant (2008) 0.79

Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant (1993) 0.79

Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood (1987) 0.79

B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant (1988) 0.79

Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol (2007) 0.78

Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine. Am J Hematol (2011) 0.78

Predominant 45,X,--Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis. Cancer Genet Cytogenet (1996) 0.77

Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation (1993) 0.77

Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis. J Mol Diagn (2010) 0.77

Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia. Bone Marrow Transplant (2005) 0.77

Cytogenetics and bone marrow transplantation. Cancer Genet Cytogenet (1986) 0.76

Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukaemia. Br J Haematol (2010) 0.76

Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood (1989) 0.76

An unusual case of donor-derived myelodysplastic syndrome following double-unit umbilical cord blood transplantation in acute lymphoblastic leukemia. Am J Hematol (2012) 0.76

Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation. Bone Marrow Transplant (2012) 0.76

Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. Br J Haematol (1992) 0.76

Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia. Bone Marrow Transplant (2006) 0.76

[Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia]. Rinsho Ketsueki (2002) 0.76

Development of donor cell leukemia mimicking hematogones after unrelated cord blood transplantation for relapsed acute lymphoblastic leukemia. Rinsho Ketsueki (2013) 0.76

Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making. Int J Hematol (2011) 0.76